It clearly summarized 38 AFG3L2 variants in patient cohorts from their own as well as other studies where pathogenic variants related to optic neuropathy were clustered in the ATPase domain affecting either of the functions related with ATP hydrolysis, ATP binding, and substrate interaction. The gene discussed is AFG3L2; the disease is optic nerve disorder.